Reported pain relief from stem cell infusions appears to peak around 3–4 months, with gradual attenuation thereafter. Some patients describe sustained benefit at 9–12 months; others note decline by month 6. No standardised outcome assessments across trials permit precise duration statements. Repeat infusions are proposed by some clinics but lack safety data on cumulative dosing. Long-term durability remains unknown.
Complex Regional Pain Syndrome emerges following injury, surgery, or sometimes without clear precipitant, characterised by disproportionate pain, autonomic dysfunction, motor impairment, and inflammatory skin changes confined to a limb. Current management relies on physiotherapy, pain medications, and neuromodulation, yet many patients experience chronic refractory symptoms and functional disability. Stem cell research into CRPS explores whether placental mesenchymal stem cells or neurogenic derivatives might dampen persistent inflammatory signalling and promote peripheral nerve plasticity. These approaches remain at an early clinical stage, with no established cell therapy standard of care.
Am I a candidate? → · Complex Regional Pain Syndrome: full overview → · Complex Regional Pain Syndrome cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估